共 53 条
[1]
Siegel R(2013)Cancer statistics, 2013 CA Cancer J Clin 63 11-30
[2]
Naishadham D(2011)FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer N Engl J Med 364 1817-1825
[3]
Jemal A(2013)Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine N Engl J Med 369 1691-1703
[4]
Conroy T(2009)Phase II trial of erlotinib in advanced pancreatic cancer (PC) J Clin Oncol 27 4609-1966
[5]
Desseigne F(2007)Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 25 1960-388
[6]
Ychou M(2006)Pharmacodynamic separation of epidermal growth factor receptor tyrosine kinase inhibitors and chemotherapy in non-small-cell lung cancer Clin Lung Cancer 7 385-553
[7]
Von Hoff DD(2007)Schedule-dependent apoptosis in K-ras mutant non-small-cell lung cancer cell lines treated with docetaxel and erlotinib: rationale for pharmacodynamic separation Clin Lung Cancer 8 548-1041
[8]
Ervin T(1989)High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas Int J Cancer 43 1037-7782
[9]
Arena FP(1988)KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas Nucl Acids Res 16 7773-1261
[10]
Tang P(2010)Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer J Clin Oncol 28 1254-2119